ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 60 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | 0.0% | 19,633 | +6.8% | 0.00% | – |
| Q1 2022 | $5,000 | -54.5% | 18,383 | -2.8% | 0.00% | – |
| Q4 2021 | $11,000 | -35.3% | 18,908 | +12.5% | 0.00% | – |
| Q3 2021 | $17,000 | -29.2% | 16,805 | -4.7% | 0.00% | – |
| Q2 2021 | $24,000 | -25.0% | 17,642 | -4.9% | 0.00% | – |
| Q1 2021 | $32,000 | +77.8% | 18,552 | +28.8% | 0.00% | – |
| Q4 2020 | $18,000 | -5.3% | 14,399 | +6.7% | 0.00% | – |
| Q3 2020 | $19,000 | +26.7% | 13,497 | +6.2% | 0.00% | – |
| Q2 2020 | $15,000 | -50.0% | 12,709 | -51.0% | 0.00% | – |
| Q1 2020 | $30,000 | +7.1% | 25,914 | +102.6% | 0.00% | – |
| Q3 2019 | $28,000 | – | 12,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |